RecallDepth
Class II Ongoing

Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-410-02

This recall is currently active, issued December 17, 2025. It was issued by Cipla Usa, Inc..

Company
Cipla Usa, Inc.
Recall Initiated
November 14, 2025
Posted
December 17, 2025
Recall Number
D-0224-2026
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
63,504 bottles
Firm Location
Warren, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.

Distribution

Nationwide in the US

Lot / Code Info

Lot, expiry: Lot 4PB0109, exp 1/31/2026; Lot 5PB0172, exp 1/31/2027

More recalls by Cipla Usa, Inc.

View all recalls by this company →

Other recent Class II Drug recalls